Holen Sie sich die Stockscreener-App
3.40
3.34%
0.11
Handel nachbörslich:
3.24
-0.16
-4.71%
Schlusskurs vom Vortag:
$3.29
Offen:
$3.28
24-Stunden-Volumen:
932.53K
Relative Volume:
1.23
Marktkapitalisierung:
$382.50M
Einnahmen:
$69.56M
Nettoeinkommen (Verlust:
$-240.05M
KGV:
-1.1525
EPS:
-2.95
Netto-Cashflow:
$-121.90M
1W Leistung:
+4.62%
1M Leistung:
+24.54%
6M Leistung:
+89.94%
1J Leistung:
+22.30%
1-Tages-Spanne:
$3.16
$3.43
1-Wochen-Bereich:
$3.04
$3.43
52-Wochen-Spanne:
$1.05
$3.97
Adc Therapeutics Sa Stock (ADCT) Company Profile
Firmenname
Adc Therapeutics Sa
Sektor
Branche
Telefon
41 21 653 02 00
Adresse
BIOPOLE, EPALINGES
Vergleichen Sie ADCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.40 | 348.75M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Eingeleitet | Guggenheim | Buy |
| 2023-08-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Eingeleitet | CapitalOne | Overweight |
| 2022-11-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Eingeleitet | Wolfe Research | Outperform |
| 2021-08-17 | Fortgesetzt | Jefferies | Buy |
| 2021-08-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | Stifel | Hold |
| 2020-10-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-06-09 | Eingeleitet | BofA/Merrill | Buy |
| 2020-06-09 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Adc Therapeutics Sa Aktie (ADCT) Neueste Nachrichten
Will breakout in ADC Therapeutics SA lead to full recoveryLayoff News & Expert Approved Momentum Trade Ideas - Newser
Applying sector rotation models to ADC Therapeutics SA2025 Macro Impact & Safe Entry Momentum Stock Tips - Newser
What are ADC Therapeutics SA’s earnings expectationsTrade Risk Assessment & Fast Entry Momentum Alerts - khodrobank.com
News impact scoring models applied to ADC Therapeutics SAWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
Can technical indicators confirm ADC Therapeutics SA’s reversalTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
What institutional flow reveals about ADC Therapeutics SAWeekly Investment Report & Entry Point Confirmation Signals - Newser
Forecasting ADC Therapeutics SA price range with options dataTake Profit & Fast Entry High Yield Tips - Newser
ADC Therapeutics SA stock prediction for this week2025 Pullback Review & AI Driven Stock Reports - Newser
Is ADC Therapeutics SA stock ready for a breakoutMarket Movement Recap & High Conviction Buy Zone Alerts - Newser
ADC Therapeutics SA stock trend outlook and recovery pathEarnings Overview Summary & Stock Portfolio Risk Management - Newser
Will earnings trigger a reversal in ADC Therapeutics SAQuarterly Performance Summary & Weekly Breakout Stock Alerts - Newser
Published on: 2025-09-03 02:44:03 - Newser
ADC Therapeutics SA recovery potential after sell off2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Will ADC Therapeutics SA rebound enough to break evenPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser
Analyzing drawdowns of ADC Therapeutics SA with statistical tools2025 Bull vs Bear & Daily Market Momentum Tracking - Newser
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PR Newswire
Is ADC Therapeutics SA stock poised for growthJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Is ADC Therapeutics SA stock influenced by commodity pricesPortfolio Profit Report & Daily Stock Momentum Reports - khodrobank.com
Identifying reversal signals in ADC Therapeutics SASwing Trade & Fast Gain Stock Tips - Newser
Is ADC Therapeutics SA part of any major index2025 Technical Patterns & Daily Growth Stock Investment Tips - khodrobank.com
Is ADC Therapeutics SA Forming a Consolidation Base2025 Sector Review & Safe Entry Momentum Tips - beatles.ru
What’s the outlook for ADC Therapeutics SA’s sectorPortfolio Gains Report & Smart Investment Allocation Insights - khodrobank.com
Analyzing ADC Therapeutics SA with risk reward ratio chartsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
A | Is ADC Therapeutics SA in a bullish channel2025 Key Highlights & Growth Focused Entry Reports - khodrobank.com
Neuroendocrine tumors Pipeline Analysis, 2025 by DelveInsight | RayzeBio, Inc., Camurus, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp - Barchart.com
ADC Therapeutics SA’s Beta Climbs After Market Volatility getLinesFromResByArray error: size == 0 - kangso.co.kr
How to monitor ADC Therapeutics SA with trend dashboards2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Developing predictive dashboards with ADC Therapeutics SA dataJuly 2025 Momentum & Low Drawdown Momentum Trade Ideas - Newser
What does recent volatility data suggest for ADC Therapeutics SAJuly 2025 Closing Moves & Reliable Breakout Forecasts - Newser
Earnings visualization tools for ADC Therapeutics SAForecast Cut & Daily Entry Point Trade Alerts - Newser
Measuring ADC Therapeutics SA’s beta against major indicesWeekly Risk Report & Community Consensus Picks - Newser
Using data models to predict ADC Therapeutics SA stock movementJuly 2025 WrapUp & Entry Point Strategy Guides - Newser
Advanced analytics toolkit walkthrough for ADC Therapeutics SATrade Risk Report & AI Based Buy and Sell Signals - Newser
What MACD and RSI say about ADC Therapeutics SATreasury Yields & Community Verified Trade Alerts - Newser
Published on: 2025-08-31 01:33:03 - Newser
Published on: 2025-08-31 00:12:31 - Newser
How to escape a deep drawdown in ADC Therapeutics SA2025 EndofYear Setup & Risk Adjusted Swing Trade Ideas - Newser
analyzing adc therapeutics sa with risk reward ratio chartsJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Finanzdaten der Adc Therapeutics Sa-Aktie (ADCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):